Patient Reported Outcomes With WaveLight Plus LASIK

Enrolling by invitationOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

July 24, 2025

Primary Completion Date

September 1, 2026

Study Completion Date

September 1, 2026

Conditions
Myopia
Interventions
DEVICE

Wavelight Plus

"The WaveLight EX500 laser system, in conjunction with INNOVEYES Sightmap, is indicated for use in INNOVEYES Laser Assisted In-Situ Keratomileusis (wavelight plus1 LASIK) treatments:~* or the reduction or elimination of myopia or myopia with astigmatism, in eyes with spherical equivalent (SE) more than -1.00 and up to -9.00 diopters (D), with up to -8.00 D of spherical component (in minus cylinder format) and up to -3.00 D of astigmatic component at the spectacle plane, based on the INNOVEYES Sightmap Measured Refraction,~* in patients with magnitude of the spherical equivalent (SE) difference between the Manifest Refraction (MRSE) and the Sightmap measured refraction SE being less than 0.75D,~* in patients who are 18 years of age or older, and~* for patients with documentation of a stable manifest refraction defined as 0.5 D preoperative spherical equivalent shift over one year prior to surgery."

Trial Locations (1)

55416

Ovo Lasik + Lens, Saint Louis Park

All Listed Sponsors
collaborator

Sengi

INDUSTRY

lead

OVO LASIK + Lens

OTHER